RareKids-CAN Offer Subsidized Services for Investigator-initiated Academic Clinical Trials
RareKids-CAN offers a range of subsidized services for investigator-initiated (academic-led) pediatric rare disease clinical trials. The goal of these services is to stretch project funds further, ensuring greater impact and cost savings. Below is the list of subsidized services offered:
100% Subsidized Services (RareKids-CAN will cover 100% of the cost of the following services):
-
- Consultations: We will conduct a robust consultation to identify areas of needs for your project with valuable involvement from relevant sub platforms based on your project needs to ensure your project receives adequate support.
- High-level project management: An experienced project manager will ensure efficient coordination, oversight, and successful execution from inception to completion for your clinical trial.
- Database build (not including management): We will provide project-specific electronic case report form (e-CRF) development and database management in a validated REDCap database housed at the Women and Children’s Health Research Institute (WCHRI).
- Data Safety Monitoring Board: From our repository of individuals with specific expertise relevant to your project, we facilitate a centralized data safety monitoring board to ensure participant safety and provide expertise on clinical trial conduct for continuation, modification, or termination.
50% Subsidized Services (RareKids-CAN will cover 50% of the total cost of the following services):
-
- Regulatory submissions: We assist study teams in the preparation and submission of clinical trial applications, investigational testing authorizations, and single-patient study applications for regulated clinical trials to Health Canada. We will also assist in adverse event reporting.
- Monitoring: We have a dedicated and experienced monitoring team to perform risk-based remote and on-site monitoring to meet the Health Canada required sponsor obligations.
All other services are 100% cost recovered (i.e., RareKids-CAN will not subsidize)
If you have a clinical trial that require these services or would like to further discuss, you can complete the project intake form.
Read next...
NMD4C Hosts 2nd Annual Clinical Summer School in Calagry!
On September 24. 2026 the second annual NMD4C Clinical Summer School brought together 25 neuromuscular fellows from across Canada to the University of Calgary for a day of hands-on learning, discussion, connection, and collaboration. We like thank our program sponsors FUJIFILM Sonosite for their unwavering contribution to our annual program. We would also like to thank Summer School co-leads Drs. Marianne Nury and Gordon Jewett, as well as the workshop leads Drs. Grayson Beecher, Theodore Mobach, Christopher White and Shahin Khayambashi, for their time, expertise, and commitment to educating and supporting the next generation of neuromuscular clinicians.
2027 NMD4C–RARE.Qc Basic Science Research Summer School Applications Are Now Open!
Deadline: December 1, 2026
2027 NMD4C–RARE.Qc Basic Science Research Summer School Applications Are Now Open!
The summer school offers neuromuscular and rare disease research trainees the opportunity to participate in an intensive three-day training program focused on cutting-edge experimental and translational research techniques.
